4.8 Article

BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300

期刊

CANCER RESEARCH
卷 73, 期 4, 页码 1308-1317

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-12-2489

关键词

-

类别

资金

  1. [R01 CA136705]
  2. [R01 CA104397]
  3. [R01 CA132580]

向作者/读者索取更多资源

The mechanisms through which the metastasis suppressor gene BRMS1 functions are poorly understood. Herein, we report the identification of a previously undescribed E3 ligase function of BRMS1 on the histone acetyltransferase p300. BRMS1 induces polyubiquitination of p300, resulting in its proteasome-mediated degradation. We identify BRMS1 as the first eukaryote structural mimic of the bacterial IpaH E3 ligase family and establish that the evolutionarily conserved CXD motif located in BRMS1 is responsible for its E3 ligase function. Mutation of this E3 ligase motif not only abolishes BRMS1-induced p300 polyubiquitination and degradation, but importantly, dramatically reduces the metastasis suppressor function of BRMS1 in both in vitro and in vivo models of lung cancer metastasis. Cancer Res; 73(4); 1308-17. (C)2013 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer

Szymon J. Szymura, Jacob P. Zaemes, David F. Allison, Sheena H. Clift, Jaclyn M. D'Innocenzi, Lisa G. Gray, Brian D. McKenna, Benjamin B. Morris, Stefan Bekiranov, Robin D. LeGallo, David R. Jones, Marty W. Mayo

CELL COMMUNICATION AND SIGNALING (2019)

Article Cardiac & Cardiovascular Systems

Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients

Tamar B. Nobel, Michael Curry, Renee Gennarelli, David R. Jones, Daniela Molena

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)

Article Cardiac & Cardiovascular Systems

Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis

Giye Choe, Amanda Ghanie, Gregory Riely, Andreas Rimner, Bernard J. Park, Manjit S. Bains, Valerie W. Rusch, Prasad S. Adusumilli, Robert J. Downey, David R. Jones, James Huang

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)

Editorial Material Cardiac & Cardiovascular Systems

American Association for Thoracic Surgery: Maintaining the mission during the coronavirus disease 2019 (COVID-19) pandemic

Marc R. Moon, David R. Jones, David H. Adams, Vaughn A. Starnes

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network

Mara Antonoff, Leah Backhus, Daniel J. Boffa, Stephen R. Broderick, Lisa M. Brown, Phillip Carrott, James M. Clark, David Cooke, Elizabeth David, Matt Facktor, Farhood Farjah, Eric Grogan, James Isbell, David R. Jones, Biniam Kidane, Anthony W. Kim, Shaf Keshavjee, Seth Krantz, Natalie Lui, Linda Martin, Robert A. Meguid, Shari L. Meyerson, Tim Mullett, Heidi Nelson, David D. Odell, Joseph D. Phillips, Varun Puri, Valerie Rusch, Lawrence Shulman, Thomas K. Varghese, Elliot Wakeam, Douglas E. Wood

ANNALS OF THORACIC SURGERY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Diagnosis and Treatment for Early Stage Non-small Cell Lung Cancer Preface

David R. Jones, Hiroshi Date

GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2020)

Article Cardiac & Cardiovascular Systems

Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection

Neel P. Chudgar, Shi Yan, Meier Hsu, Kay See Tan, Katherine D. Gray, Daniela Molena, Tamar Nobel, Prasad S. Adusumilli, Manjit Bains, Robert J. Downey, James Huang, Bernard J. Park, Gaetano Rocco, Valerie W. Rusch, Smita Sihag, David R. Jones, James M. Isbell

Summary: The study compared the observed and predicted outcomes after pulmonary resections between SURPAS and NSQIP SRC. Results showed no significant differences in discrimination performance between the two models for most complications, except for renal failure. The NSQIP SRC performed better in discriminating the risk of renal failure compared to SURPAS.

ANNALS OF THORACIC SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy

Raul Caso, Gregory D. Jones, Kay See Tan, George J. Bosl, Samuel A. Funt, Joel Sheinfeld, Victor E. Reuter, David Amar, Gregory Fischer, Daniela Molena, Gaetano Rocco, Manjit S. Bains, Darren R. Feldman, David R. Jones

Summary: This study explored the outcomes of thoracic metastasectomy in GCT patients who received first-line chemotherapy alone versus salvage chemotherapy. Patients treated with salvage chemotherapy had more aggressive disease and worse PFS, but achieved encouraging OS. Aggressive thoracic metastasectomy plays an integral role in treating GCT patients with residual thoracic disease after chemotherapy.

ANNALS OF THORACIC SURGERY (2021)

Article Oncology

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Joshua E. Reuss, Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak, Mara Lanis, Joseph C. Murray, Hok Yee Chan, Caroline McCarthy, Daphne Wang, James R. White, Stephen Yang, Richard Battafarano, Stephen Broderick, Errol Bush, Malcolm Brock, Jinny Ha, David Jones, Taha Merghoub, Janis Taube, Victor E. Velculescu, Gary Rosner, Peter Illei, Drew M. Pardoll, Suzanne Topalian, Jarushka Naidoo, Ben Levy, Matthew Hellmann, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Cardiac & Cardiovascular Systems

The American College of Surgeons Surgical Risk Calculator performs well for pulmonary resection: A validation study

Neel Chudgar, Shi Yan, Meier Hsu, Kay See Tan, Katherine D. Gray, Daniela Molena, David R. Jones, Valerie W. Rusch, Gaetano Rocco, James M. Isbell

Summary: The NSQIP SRC can reasonably predict postoperative complications in patients undergoing pulmonary resection, except for certain calibration issues.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Surgery

A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma

Gregory D. Jones, Whitney S. Brandt, Ronglai Shen, Francisco Sanchez-Vega, Kay See Tan, Axel Martin, Jian Zhou, Michael Berger, David B. Solit, Nikolaus Schultz, Hira Rizvi, Yuan Liu, Ariana Adamski, Jamie E. Chaft, Gregory J. Riely, Gaetano Rocco, Matthew J. Bott, Daniela Molena, Marc Ladanyi, William D. Travis, Natasha Rekhtman, Bernard J. Park, Prasad S. Adusumilli, David Lyden, Marcin Imielinski, Marty W. Mayo, Bob T. Li, David R. Jones

Summary: The integration of genomic and clinicopathologic features can better predict recurrence in early-stage LUAD patients after surgical resection, potentially enhancing accrual to clinical trials.

JAMA SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Predictors of survival following surgical resection of limited-stage small cell lung cancer

Nicolas Zhou, Matthew Bott, Bernard J. Park, Eric Vallieres, Candice L. Wilshire, Kazuhiro Yasufuku, Jonathan D. Spicer, David R. Jones, Boris Sepesi

Summary: The study highlights the survival benefit of adjuvant chemotherapy in limited-stage SCLC, but did not find a statistically significant influence from mediastinal PORT or PCI in the cohort. Larger prospective studies are needed to determine the benefits of PORT or PCI in a surgically resected limited-stage SCLC population.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Editorial Material Cardiac & Cardiovascular Systems

Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons

David R. Jones, Yi-Long Wu, Masahiro Tsuboi, Roy S. Herbst

Summary: The ADAURA trial demonstrated significant benefits of receiving the third-generation EGFR-tyrosine kinase inhibitor osimertinib after lung cancer resection. The results are expected to impact clinical practice and future directions in adjuvant therapy for lung cancer. The role of thoracic surgeons becomes more crucial in ensuring genetic profiling, appropriate adjuvant therapy, and patient participation in future trials studying targeted therapies.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Oncology

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer

Gregory D. Jones, Harry B. Lengel, Meier Hsu, Kay See Tan, Raul Caso, Amanda Ghanie, James G. Connolly, Manjit S. Bains, Valerie W. Rusch, James Huang, Bernard J. Park, Daniel R. Gomez, David R. Jones, Gaetano Rocco

Summary: Surgical resection of the primary tumor in patients with oligometastatic non-small cell lung cancer can lead to encouraging long-term survival, especially in those who undergo neoadjuvant therapy and have limited intrathoracic disease.

CANCERS (2021)

Article Obstetrics & Gynecology

Diaphragm hernia after debulking surgery in patients with ovarian cancer

Sarah Ehmann, Emeline M. Aviki, Yukio Sonoda, Thomas Boerner, Dib Sassine, David R. Jones, Bernard Park, Murray Cohen, Norman G. Rosenblum, Dennis S. Chi

Summary: Over 80% of patients with epithelial ovarian cancer present with advanced disease requiring extensive upper abdominal surgery. A rare but serious complication post-surgery is diaphragmatic hernia, which may result in various symptoms and require prompt surgical correction.

GYNECOLOGIC ONCOLOGY REPORTS (2021)

暂无数据